expert view

Dipan Mehta, Director, Elixir Equities, says the more disappointing part of Infosys is definitely the guidance. At 4-7% constant currency, it is not going to enthuse many investors. So…
Read More...

Rohit Agarwal, Senior Fund Manager - Equity Investments, Kotak Life Insurance, says pharma is a heterogeneous sector and we have to always evaluate pharma on a bottom-up basis. At…
Read More...

Sunil Subramaniam, MD & CEO, Sundaram Mutual, says that because of the volatility in the markets, most of the advisors and distributors are pushing their customers not only to start…
Read More...

Trideep Bhattacharya, CIO-Equities, Edelweiss MF, says as we head along towards the middle of this year, towards the back half of this year, we would see a slowdown materialise in some…
Read More...

“After the recent changes in regulations for debt funds, we will see a change in the choice of instruments. Direct bonds and maybe credit AIFs, and similar types of products, absolute…
Read More...

Amitabh Chaudhry, MD & CEO, Axis Bank, remains confident about gaining market share and says that Axis, one of the largest private sector banks in the country, is due for a…
Read More...

It is better not to be very bullish on IT stocks at this stage because there is uncertainty and delay in decision making. US financials are a big segment for many of these companies and…
Read More...

"So, emerging markets will be your first port of call where you are going to see growth either from a recovery or for just general growth compared to the rest of the world," says Andrew…
Read More...

Feroze Azeez, Deputy CEO, Anand Rathi Private Wealth Management, says If one is going to get 8% with a triple AAA rated corporate bond and 7.4% with the Government of India, one should…
Read More...

“Anybody who understands the risk of a slightly limited mandate investment, could consider these funds. They should look at the themes which they are comfortable with. They could also…
Read More...